Adeno-associated virus (AAV) is a single-stranded DNA packaging virus of the Parvoviridae family and belongs to the genus Dependoparvovirus. AAV-based vectors are being developed and used as gene delivery biologics to treat a variety of monogenic diseases. AAV virions consist of a non-enveloped capsid with T = 1 icosahedral symmetry and a diameter of approximately 260 Å. They are assembled from 60 viral proteins (VPs): VP1 (≈82 kDa), VP2 (≈73 kDa), and VP3 (≈61 kDa) in a ratio of approximately 1:1:10. These VPs share a C-terminus that contains the entire VP3. Compared to VP3, the N-termini of VP1 and VP2 are extended, and they share a region of approximately 65 amino acids (aa), while the N-terminus of VP1 (VP1u) has approximately 137 more amino acids than VP2. The N-terminal regions of VP1 and VP2 contain conserved elements required for AAV infection, such as the phospholipase A2 (PLA2) domain, calcium binding domain, and nuclear localization signal. Overall, the VP1 amino acid sequence homology of different AAV serotypes ranges from 57% to 99%.
Recombinant AAV vectors (rAAV) are able to package recombinant DNA into AAV capsids and use the natural ability of the capsids to deliver therapeutic genes to target cells and express them, making them one of the most successful tools for restoring defective gene function to treat monogenic diseases. 13 human and primate AAV serotypes and numerous genomic isolates have been described and have been classified into six branches or single clonal isolates from A to F. AAV5 is being developed as a gene delivery vector for a variety of diseases, including hemophilia and Huntington's disease, and has been shown to have efficient transduction capabilities in the liver, lungs, skeletal muscle, and central nervous system.
Central cholinergic circuits play a role in regulating feeding behavior. The dorsomedial hypothalamus (DMH) is considered an appetite-stimulating center and contains cholinergic neurons. Here, researchers investigated the role of DMH cholinergic neurons in controlling food intake. Mice lacking the Chat gene in the DMH lost weight compared to controls. Chemogenetic activation of DMH cholinergic neurons promoted food intake. This orexigenic effect was further supported by experiments using optogenetic stimulation of DMH cholinergic neurons. DMH cholinergic neurons innervate proopiomelanocortin neurons in the arcuate nucleus (ARC) of the hypothalamus. Treatment with acetylcholine (ACh) enhanced GABAergic inhibitory transmission to ARC POMC neurons, which was blocked by muscarinic receptor antagonists. Direct activation of cholinergic fibers in the ARC readily stimulates food intake that is also abolished by the muscarinic receptor antagonist.
Here, the researchers first examined whether ACh in the DMH regulates body weight. To delete the Chat gene in DMH cholinergic neurons, they bilaterally injected AAV5-hSyn-mCherry (control) or AAV5-hSyn-mCherry-Cre viruses into the DMH of a floxed mutant that possesses loxP sites flanking exons 3 and 4 of the Chat gene (ChATflox/flox) (Figure 1A). The study found that male mice lacking the Chat gene in the DMH gained significantly less weight than control mice fed a normal diet (Figure 1B, AAV5-con, n = 12 mice; AAV5-Cre, n = 12 mice). Although female mice also showed a trend of decreased body weight, there was no significant difference between mice infected with AAV5-control or AAV5-Cre (Figure 1B, AAV5-con, n = 11 mice; AAV5-Cre, n = 11 mice). These findings suggest that ACh in DMH cholinergic neurons is required for body weight maintenance.
Figure 1. A. Schematic diagram showing the injection of AAV vectors into the DMH of ChATflox/flox mice. B. Effects of loss of DMH cholinergic function on mouse body weight. (Jeong J H, et al., 2017)
Customer Reviews
Efficient Neuronal Transduction
The AAV5-hSyn-mCherry vector from Creative Biogene has significantly enhanced our ability to transduce neurons with high specificity and efficiency, leading to clearer insights in our neuroscience research.
Write a Review